en English

Pharmacy Hub

Together we will provide world leading trans healthcare

 

In order to ensure our service users get access to the best standards of care, we only work with pharmacists who are regulated in their country and who can ensure the medication they dispense is legitimate and safe.

This section of our website aims to inform our pharmacy colleagues about our approach and provide any reassurance, should it be needed, about the role they can play in providing care to this population.

If you believe that trans patients should be able to access safe, effective, well-led, responsive care, and you would like to join our network of pharmacies to receive direct referrals from us, please leave us your details and become a trusted partner.

Working with our pharmacy colleagues
Risk assessment and management
How GenderGP operates
GPhC Guidance

Pharmacy FAQs

If you are a patient and you have any questions relating to how we work with pharmacies please visit our FAQs page.

Our team of gender specialists carry out personal, physical, social, gender assessments according to need. We adopt a multidisciplinary approach. We do not believe in putting people through mandatory lengthy assessments in order to validate their gender. People who come to us understand their own experience better than anyone, our role is to help them to begin – or continue – their journey. We simply work with our service users to gather key information so that we understand more about them and their transition goals and our medical team can recommend the best course of action. You can read more about our approach to assessments here.

Load More

Capacity is obtained via written and verbal communication for all patients. Anyone who is over the age of 16 can be presumed to be able to have the capacity to consent to their own medical treatment unless concerns are raised. Anyone under the age of 16 can consent to their own treatment, as long as they are able to show that they can understand the implications of that treatment. Of course there will be people who are over 16 who will be unable to understand and make decisions, just as there will be people under 16 who are unable to consent. A full overview of our approach to consent can be found here.

Load More

At GenderGP we take the safeguarding of all patients very seriously. Our safeguarding statement and policies can be accessed here.

Load More

As an international organisation we are not bound by English regulators. However, all of our specialists are individually regulated for each of the activities they carry out in the countries in which they are professionally registered.

Load More

GenderGP is a global organisation which provides health and wellbeing services to transgender people and those who care for them. Our organisation comprises medical and therapeutic gender specialists from all over the world who are regulated in each area of their specialism in the countries in which they are based.

Load More

Yes. Please complete the following form and a member of the team will contact you.

Load More

There is currently no specific training available which relates to this group of patients. The medication used and the monitoring required within this patient group, is no different to those who are being treated for menopause, endometriosis, prostate cancer, precocious puberty, constitutional delay in puberty.

Gender dysphoria is not a highly specialised field that involves dangerous medication requiring comprehensive monitoring. The benefits of having access to care far outweigh the risks associated with the denial of that care, particularly in light of NHS waiting times that are in breach of the NHS constitution.

In balancing the risks of providing essential pharmacy services to this patient cohort, there must also be an analysis of the risk of not providing services. Patients who struggle to get access to medical and pharmaceutical healthcare services often turn to the grey or black market.

Load More

Yes, there are plenty of things you can do including the provision of training to your pharmacy team to ensure their approach is inclusive visit: https://lgbt.foundation/prideinpractice to find out more. You can also sign up to our pharmacy network here.

Load More

There is no recognised training or qualification in this field, so all learning is by personal professional development. GenderGP and its doctors follow the peer-reviewed, published International Guidance from the WPATH, The Endocrine Society, The University of California, San Francisco (UCSF) and Australia. Find out more here.

Load More

Yes. All of our doctors have been carefully selected for their knowledge, skills and attitude in the field of gender-related healthcare and they follow strict International guidance for treatment protocols. Doctors working with GenderGP support thousands of patients in their capacity as gender specialists.

Load More

It is well known that many medications that are prescribed are unlicensed for use in trans healthcare. You can read GMC guidance about this here and GPhC advice here. All of our clinicians prescribe in line with The Endocrine Society Guidelines for the Care of Transgender Patients. Our prescribing protocol and a list of prescribed medications can be found here.

Load More

Yes you can. Please click on this link to view our template SLA.

Load More

Absolutely. You can see our reviews on both Trustpilot and Google and the testimonials page of the GenderGP website.

Load More

Leading experts worldwide agree that: “[puberty suppression and subsequent gender affirming hormones] is the most widely accepted and preferred clinical approach in health services for transgender people around the world.”

Load More

Dr Helen Webberley has not been struck off. She is currently on an interim order of suspension while her model of care is evaluated. No finding of fault has been made against her medical registration. As the founder of GenderGP she continues to campaign tirelessly for improvements in trans healthcare, she is not currently practising as a GP. If you would like to read more about Dr Helen you can do so here.

Load More

In December, a high court ruling determined that it was unlikely that those under the age of 16 could consent to treatment. There has been much controversy surrounding the case and the Tavistock and Portman clinic (the only NHS provider of care to trans youth) has since been granted an appeal. This is due to take place in March 2021. We have compiled the following resource for anyone wishing to better understand the implications of the ruling.

Load More

Yes! The NHS has a legal duty to provide this care. While the UK is falling behind in its provision to the trans community and specifically trans youth, leading centres of excellence worldwide have issued clear guidance in recent years which promotes the benefits of affirmative care. At GenderGP we follow this best practice to ensure all trans individuals, wherever they are in the world and however old they are, have access to the care they need.

Load More

In recent years, understanding around what it means to be transgender has increased significantly. This has led to many more people stepping forward and asking for help with their social, medical and legal transition. In many countries, medical services have failed to keep up with demand, with too few healthcare professionals feeling able, or willing to help. A reluctance all too often driven by social, medical and political prejudice. These factors have also driven the wider narrative on trans healthcare with very strong opinions coming to the fore from prominent figures who do not support the notion that trans people exist, much less that they should be affirmed.

Load More

GenderGP is owned by a company called Harland International Ltd which is registered in Hong Kong. It is fully regulated to operate in all countries across the world, 100% legally. We are also focused on ensuring any medication prescribed is appropriate, legal and safe, as are the pharmacies to which we signpost our patients.

Load More

A lack of education and awareness around trans issues has led to a culture of fear. This hampers safe and effective provision of care for this patient group. Active anti-trans lobbyists have raised unnecessary and unfounded concerns, particularly in relation to trans youth, and this has made regulators very concerned. Although this concern appears in other countries, it seems that the UK is falling behind in understanding the need for equality in healthcare for trans patients.

Load More

All decisions are made by a multidisciplinary team which includes several doctors. If you would like details of the specific doctor related to a specific patient then, you can request that information here.

Load More

If you have any concerns please complete the following form and a member of the team will contact you.

Incident reporting here: https://www.gendergp.com/ask-gendergp-pharmacists/

Safeguarding here: https://www.gendergp.com/pharmacy-safeguarding/

 

Load More

Testosterone is considered as a Class C, Schedule 4 Part2 controlled drug because it is in the same class as anabolic steroids which have been open to abuse because of their body enhancing properties.

There has historically been some concern by pharmacists that they are not allowed to dispense controlled drugs against an EU prescription, however the British National Formulary (BNF) gives very clear guidance on prescribing and dispensing laws in the UK and it advises:

Schedule 4 Part II includes androgenic and anabolic steroids, clenbuterol, chorionic gonadotrophin (HCG), non-human chorionic gonadotrophin, somatotropin, somatrem, and somatropin. Controlled drug prescription requirements do not apply and Schedule 4 Controlled Drugs are not subject to safe custody requirements.

Testosterone used to achieve masculinisation in trans masculine people is a core part of the medication used for medical transition. Used in this context it is a safe and well evaluated aspect of gender-affirming care.

Load More